762315004: leucemia mieloide aguda relacionada con tratamiento debida a la administración de agente antineoplásico y posterior a ella (trastorno)

concepto de SNOMED CT\Clinical finding (finding)\...

\tumoración de estructura corporal\masa de estructura linforreticular\Neoplasm of bone marrow (disorder)\Therapy-related myelodysplastic syndrome (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\tumoración de estructura corporal\neoplasia hematológica\Neoplasm affecting hematopoietic structure (disorder)\Therapy-related myelodysplastic syndrome (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent

\hallazgo relacionado con un procedimiento (hallazgo)\Complication of chemotherapy (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\hallazgo relacionado con un procedimiento (hallazgo)\hallazgo posprocedimiento (hallazgo)\Disorder following clinical procedure\complicación neoplásica de procedimiento (trastorno)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\hallazgo relacionado con un procedimiento (hallazgo)\hallazgo posprocedimiento (hallazgo)\Disorder following clinical procedure\Haematologic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\hallazgo relacionado con un procedimiento (hallazgo)\Complication of procedure\complicación neoplásica de procedimiento (trastorno)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\hallazgo relacionado con un procedimiento (hallazgo)\Complication of procedure\Haematologic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\hallazgo relacionado con un procedimiento (hallazgo)\Complication of procedure\complicación de procedimiento de introducción (trastorno)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent

\enfermedad\Complication of chemotherapy (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\Disorder of hematopoietic cell proliferation (disorder)\Myeloproliferative disorder (disorder)\Therapy-related myelodysplastic syndrome (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\Neoplasm and/or hamartoma (disorder)\Neoplastic disease (disorder)\Neoplasm of hematopoietic cell type (disorder)\neoplasia maligna de tejido hematopoyético, linfático y/o relacionado (trastorno)\Therapy-related myelodysplastic syndrome (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\Neoplasm and/or hamartoma (disorder)\Neoplastic disease (disorder)\Malignant neoplastic disease (disorder)\neoplasia maligna de tejido hematopoyético, linfático y/o relacionado (trastorno)\Therapy-related myelodysplastic syndrome (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\Neoplasm and/or hamartoma (disorder)\Neoplastic disease (disorder)\complicación neoplásica de procedimiento (trastorno)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\Neoplasm and/or hamartoma (disorder)\Neoplastic disease (disorder)\neoplasia hematológica\Neoplasm affecting hematopoietic structure (disorder)\Therapy-related myelodysplastic syndrome (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\trastorno de sistema corporal\Disorder of hematopoietic structure (disorder)\Neoplasm affecting hematopoietic structure (disorder)\Therapy-related myelodysplastic syndrome (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\trastorno de sistema corporal\Disorder of hematopoietic structure (disorder)\trastorno de la médula ósea\Myeloproliferative disorder (disorder)\Therapy-related myelodysplastic syndrome (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\trastorno de sistema corporal\Disorder of hematopoietic structure (disorder)\trastorno de la médula ósea\Neoplasm of bone marrow (disorder)\Therapy-related myelodysplastic syndrome (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\trastorno de sistema corporal\Haematologic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\trastorno de sistema corporal\neoplasia hematológica\Neoplasm affecting hematopoietic structure (disorder)\Therapy-related myelodysplastic syndrome (disorder)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\Disorder following clinical procedure\complicación neoplásica de procedimiento (trastorno)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\Disorder following clinical procedure\Haematologic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\Complication of procedure\complicación neoplásica de procedimiento (trastorno)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\Complication of procedure\Haematologic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\Complication of procedure\complicación de procedimiento de introducción (trastorno)\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\enfermedad\lesión medicamentosa\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent

Status: current, estado de definición: concepto suficientemente definido. Date: 30-Sep 2021. Module: módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	Disorder following clinical procedure	false	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	complicación de procedimiento de introducción (trastorno)	true	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	lesión medicamentosa	true	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	Haematologic complication of procedure	true	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	complicación neoplásica de procedimiento (trastorno)	true	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	Therapy-related myelodysplastic syndrome (disorder)	true	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	morfología asociada	neoplasia mieloide post terapia citotóxica (anomalía morfológica)	true	relación inferida	restricción existencial (metadato del núcleo)	3
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Due to	administración de agente antineoplásico (procedimiento)	true	relación inferida	restricción existencial (metadato del núcleo)	1
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	trastorno medicamentoso	false	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	Complication of procedure	false	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	secuela	false	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	Complication of chemotherapy (disorder)	true	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	es un[a]	leucemia mieloide aguda y síndrome mielodisplásico relacionados con el tratamiento (trastorno)	false	relación inferida	restricción existencial (metadato del núcleo)
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	después	administración de agente antineoplásico (procedimiento)	true	relación inferida	restricción existencial (metadato del núcleo)	2
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	morfología asociada	leucemia mielocítica aguda y síndrome mielodisplásico asociados con el tratamiento	false	relación inferida	restricción existencial (metadato del núcleo)	3
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	agente causal	Antineoplastic agent (substance)	true	relación inferida	restricción existencial (metadato del núcleo)	3
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	sitio del hallazgo	Bone marrow structure	true	relación inferida	restricción existencial (metadato del núcleo)	3

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent	es un[a]	True	Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	relación inferida	restricción existencial (metadato del núcleo)

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3635334012	Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	en	sinónimo (metadato del núcleo)	Active	uso de mayúsculas y minúsculas sin relevancia para la totalidad del término (metadato del núcleo)	módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)
3636381018	Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder)	en	descripción completa	Active	uso de mayúsculas y minúsculas sin relevancia para la totalidad del término (metadato del núcleo)	módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)
3636382013	Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent	en	sinónimo (metadato del núcleo)	Active	uso de mayúsculas y minúsculas sin relevancia para la totalidad del término (metadato del núcleo)	módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)
528261000209112	leucemia mieloide aguda relacionada con tratamiento debida a la administración de agente antineoplásico y posterior a ella	es	sinónimo (metadato del núcleo)	Active	uso de mayúsculas y minúsculas sin relevancia para la totalidad del término (metadato del núcleo)	Latin American Spanish extension module
528271000209118	leucemia mieloide aguda relacionada con tratamiento debida a la administración de agente antineoplásico y posterior a ella (trastorno)	es	descripción completa	Active	uso de mayúsculas y minúsculas sin relevancia para la totalidad del término (metadato del núcleo)	Latin American Spanish extension module